Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nobelpharma Co. Ltd.

www.nobelpharma.co.jp

Latest From Nobelpharma Co. Ltd.

Pipeline Watch: Phase III Starts With Murepavadin, CSL112 And Vibegron

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

Pipeline Watch Approvals

Japan Grants Global First Nod For Brodalumab, For Psoriasis

Japan has granted the first approval worldwide for brodalumab as a biologic therapy for psoriasis, one of two new antibodies for the disorder in a new batch of approvals that also includes Praluent and Kyprolis.

BioPharmaceutical Asia Pacific

Endometriosis: 176 Million Women And No Cure In Sight

With a gap in endometriosis treatments on the market, Citeline analyst Benjamin Graham looks at the pipeline to see what those suffering can expect in the coming years.

Therapy Areas Gynecology & Urology

Japan listing sets stage for edoxaban, vaniprevir launches

Japan has granted reimbursement prices to a batch of new drugs, including a new therapy for hepatitis C, a novel anticoagulant and a new insomnia treatment.

Cardiovascular Infectious Diseases
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Nobelpharma Co. Ltd.
  • Senior Management
  • Jin Shionura, Pres. & CEO
    Tsutomu Sugaya, Ex. Of. & CFO, Hd, Admin. Affairs & Corp. Planning
    Shigeki Shimasaki, Senior Exec. Officer & COO, R&D
    Toshihiko Asano, Exec. Officer & COO, Mktg. & Sales
  • Contact Info
  • Nobelpharma Co. Ltd.
    Phone: 3 5651 1160
    12-10 Nihonbashi-Kobunacho, Chuo-Ku
    Kyodo Bldg.
    Tokyo, 103-0024
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register